NOX
Click for more information
1.47% 6.9¢ noxopharm limited

Novartis drug is already approved. They are currently focusing...

  1. Zenox
    1,216 Posts.
    lightbulb Created with Sketch. 1375
    clock Created with Sketch.
    07/06/22
    12:19
    Post #: 61864369
    Novartis drug is already approved. They are currently focusing on distribution and undertaking other studies to increase market share in the current treatable population. As I understand, Novartis are still interested in having their treatment offered earlier in the treatment process, which may open the door for Veyonda at some point in the future. Looks like a interesting 3rd and 4th quarter for holders.
    NOX Price at posting: 28.5¢ Sentiment: Hold Disclosure: Not Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.9¢ 		Change
0.001(1.47%) 		Mkt cap ! $20.16M
Open High Low Value Volume
6.7¢ 6.9¢ 6.6¢ $13.24K 197.1K

Buyers (Bids)

No. Vol. Price($)
1 2137 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 22400 1
View Market Depth
Last trade - 12.58pm 28/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.